All stock lists
Ocugen, Inc. (NASDAQ:OCGN)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
0.72-0.02 (-2.77%)
Market cap
$244M
Health Score
Analyst consensus
Listed since
Dec 3, 2014
Website
Insider Score
––Not scored
OCGN Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
OCGN Stock Insider Trading Activity
OCGN stock’s insider trading shows 1 purchase for an estimated $25.83K and 4 sales on the open market for an estimated $1.09M by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
Scored window · last 90 days0 qualifying buys0 insiders$0 bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Musunuri Shankar CEO | Sell | 468,727 | $0.95 | $445.29K | 10.4% | 4,018,470 | Oct 9, 2026 | — | Form 4 |
| Musunuri Shankar CEO | Sell | 57,264 | $0.95 | $54.40K | 5.3% | 1,030,771 | Oct 9, 2026 | — | Form 4 |
| Musunuri Shankar CEO | Sell | 468,727 | $1.12 | $524.97K | 9.5% | 4,487,197 | Sep 9, 2026 | — | Form 4 |
| Musunuri Shankar CEO | Sell | 57,264 | $1.12 | $64.14K | 5.0% | 1,088,035 | Sep 9, 2026 | — | Form 4 |
| Johnson-Greene Treerita Essalima CFO | Buy | 21,000 | $1.23 | $25.83K | 4.2% | 521,000 | Jun 15, 2026 | BFirst BuyCFO BuyDilution | Form 4 |
| Zhang Junge Director | Option exercise | 66,929 | $1.42 | $95.04K | 5.2% | 1,359,316 | Apr 1, 2026 | — | Form 4 |
| Zhang Junge Director | Option exercise | 15,000 | $0.51 | $7.65K | 1.3% | 1,180,182 | Apr 1, 2026 | — | Form 4 |
| Zhang Junge Director | Option exercise | 112,205 | $0.46 | $51.61K | 9.5% | 1,292,387 | Apr 1, 2026 | — | Form 4 |
| Ramachandran Ramesh Other | Award | 207,300 | — | — | 11517% | 209,100 | Jan 2, 2026 | — | Form 4 |
| Musunuri Shankar CEO | Award | 3,123,201 | — | — | 170% | 4,955,924 | Jan 2, 2026 | — | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Buy (P) — Open-market or private purchase
- Sell (S) — Open-market or private sale
- Award (A) — Grant or award from the company, not a purchase
- Option exercise (M) — Exercise or conversion of an exempt derivative
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.